Please use this identifier to cite or link to this item:
標題: 重組蛋白Grb2-SH2構域專一性單株抗體篩選
Selection of Monoclonal Antibody Against Recombinant Grb2-SH2 Domain
作者: 連亭雅
Ting-Ya Lien
關鍵字: 乳癌;生長因子受體結合蛋白2;SH2 domains;Breast;Grb2;SH2 domains
引用: 1. Leistikow, B., Lung cancer rates as an index of tobacco smoke exposures: validation against black male approximate non-lung cancer death rates, 1969-2000. Prev Med, 2004. 38(5): 511-5. 2. Warnes, A.M., UK and western European late-age mortality: trends in cause-specific death rates, 1960-1990. Health Place, 1999. 5(1): 111-8. 3. Newbold, R.R., et al., Uterine carcinoma in mice treated neonatally with tamoxifen. Carcinogenesis, 1997. 18(12): 2293-8. 4. Boerner, J.L., et al., Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis. Oncogene, 2003. 22(43): 6679-89. 5. Sommer, S. and S.A. Fuqua, Estrogen receptor and breast cancer. Semin Cancer Biol, 2001. 11(5): 339-52. 6. McPherson, K., C.M. Steel, and J.M. Dixon, ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. Bmj, 2000. 321(7261): 624-8. 7. van der Geer, P., T. Hunter, and R.A. Lindberg, Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol, 1994. 10: 251-337. 8. Sawyer, T.K., Src homology-2 domains: structure, mechanisms, and drug discovery. Biopolymers, 1998. 47(3): 243-61. 9. Sudol, M., From Src Homology domains to other signaling modules: proposal of the 'protein recognition code'. Oncogene, 1998. 17(11 Reviews): 1469-74. 10. Pawson, T., G.D. Gish, and P. Nash, SH2 domains, interaction modules and cellular wiring. Trends Cell Biol, 2001. 11(12): 504-11. 11. Pawson, T. and G.D. Gish, SH2 and SH3 domains: from structure to function. Cell, 1992. 71(3): 359-62. 12. Pawson, T., Protein modules and signalling networks. Nature, 1995.373(6515): 573-80. 13. Koch, C.A., et al., SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science, 1991. 252(5006): 668-74. 14. Narula, S.S., et al., Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Structure, 1995. 3(10): 1061-73. 15. Mikol, V., et al., The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site. J Mol Biol, 1995. 246(2): 344-55. 16. Moran, M.F., et al., Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci U S A, 1990. 87(21): 8622-6. 17. Rahuel, J., et al., Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nat Struct Biol, 1996. 3(7): 586-9. 18. Songyang, Z., et al., Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol, 1994. 14(4): 2777-85. 19. Matuoka, K., et al., Ash/Grb-2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. Embo J, 1993. 12(9): 3467-73. 20. Lowenstein, E.J., et al., The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell, 1992. 70(3): 431-42. 21. Matuoka, K., et al., Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries. Proc Natl Acad Sci U S A, 1992. 89(19): 9015-9. 22. de Mol, N.J., et al., Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain. Biochim Biophys Acta, 2004. 1700(1): 53-64. 23. Clark, S.G., et al., C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature, 1992. 356(6367): 340-4. 24. Buday, L., Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins. Biochim Biophys Acta, 1999. 1422(2): 187-204. 25. Rozakis-Adcock, M., et al., The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature, 1993. 363(6424): 83-5. 26. Pawson, T. and J.D. Scott, Signaling through scaffold, anchoring, and adaptor proteins. Science, 1997. 278(5346): 2075-80. 27. Downward, J., The GRB2/Sem-5 adaptor protein. FEBS Lett, 1994. 338(2): 113-7. 28. Pawson, T., Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell, 2004. 116(2): 191-203. 29. Pelicci, G., et al., A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell, 1992. 70(1): 93-104. 30. Pendergast, A.M., et al., BCR-ABL-induced oncogenesis is mediated by directinteraction with the SH2 domain of the GRB-2 adaptor protein. Cell, 1993. 75(1): 175-85. 31. Chardin, P., et al., The Grb2 adaptor. FEBS Lett, 1995. 369(1): 47-51. 32. Pawson, T. and J. Schlessingert, SH2 and SH3 domains. Curr Biol, 1993. 3(7): 434-42. 33. Cowburn, D., Src homology adaptor proteins: more than the sum of the parts? Structure, 1995. 3(5): 429-30. 34. Schlessinger, J., SH2/SH3 signaling proteins. Curr Opin Genet Dev, 1994. 4(1): 25-30. 35. Tari, A.M., et al., Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene, 1999. 18(6): 1325-32. 36. Mitchell, D.J., et al., Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res, 2000. 56(5): 318-25. 37. Mehrhof, F.B., et al., In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation, 2001. 104(17): 2088-94. 38. Jemal, A., et al., Global cancer statistics. CA Cancer J Clin 2011,61: 69-90.. 39. LODISH, et al., Chapter 13 Signaling at the Cell Surfacce MOLECULAR CELL BIOLOGY, Fifth Edition. New York: W. H. Freeman and company,2004: 534 40. Yarden, Y., Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001 Feb,2(2): 127-37. 41. Suo, Z., et al., EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol. 2002 Jan, 196(1): 17-25. 42. Cohen, BD., et al., Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma. Biochem Soc Symp. 1998, 63: 199-210.
Cancer was the leading cause of death in Taiwan. Breast cancer was the most prevalent cancer in female. Clinical breast cancer therapies include surgery, chemical and radial therapy. Several drugs were used for chemical therapy, however, these drug treatments have many side effects, even leading to some other cancers development. The drug with low side effect is needed to avoid these side effects. Antibody, from the immune system?has high specificity to a candidate specific cell or a molecul and becomes a potential drug for targeted therapy. Cancer development comes from abnormal growth mechanism from normal cells. According to previous study, Grb2 protein (Growth factor receptor-bound protein 2) with SH2 domain (Src-homology 2 domain) was connected to cancer cell proliferation. In this study, we tried to acquire a SH2 domin specific antibody to prevent cancer cell abnormal growth. MCF-7 cell was used and its genome was served as template to amplified Grb2 gene SH2 domain fragment to further insert this DNA fragment into expression plasmid. SH2 domain fragment of Grb2 was expressed in E.coli expression system. Expressed protein was gathered as antigen to immune the mouse. After elevated immune response, mice were screened and sacrifice to obtain antibody in sera. The B Cells were fused with NS1 myeloma cells to produce hybridoma. We got 2 limes of SH2 antibody producing hybridoma after the monoclonal selection. The 6H3 antibody was highly specific to SH2 protein and will be use to enginerring for scFv drug development in the future.
其他識別: U0005-2811201416174450
Rights: 同意授權瀏覽/列印電子全文服務,2017-08-31起公開。
Appears in Collections:生命科學院碩士在職專班

Files in This Item:
File Description SizeFormat Existing users please Login
nchu-103-5101052017-1.pdf1.93 MBAdobe PDFThis file is only available in the university internal network    Request a copy
Show full item record

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.